Product Added to Cart!
$80.00

FREE
SHIPPING

100% MONEY
BACK GUARANTEE

ONLINE
SUPPORT 24/7

Available on backorder. Please allow 2-3 weeks for production.
Sku CI37782_5_G
Chem Impex
Get Bulk Quote

Product Information

Product Name
3-(3,4-Dihydroxyphenyl)-2-methyl-L-alanine sesquihydrate
Brand Name
Chem Impex
Product Number
37782
CAS
555-30-6
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
38853
IUPAC Name
(2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid
InChI Key
CJCSPKMFHVPWAR-JTQLQIEISA-N
SMILES
CC@(CC1=CC(=C(C=C1)O)O)(C(=O)O)N

Description

3-(3,4-Dihydroxyphenyl)-2-methyl-L-alanine sesquihydrate is widely utilized in research focused on:

Pharmaceutical Development: This compound is studied for its potential role in developing new medications, particularly those targeting neurological disorders due to its structural similarity to neurotransmitters.

Antioxidant Research: It is explored for its antioxidant properties, which can help in formulating supplements aimed at reducing oxidative stress in cells, benefiting health and wellness industries.

Food Science: The compound is investigated for its applications in enhancing the nutritional profile of food products, particularly in functional foods that promote health benefits.

Cosmetic Formulations: Researchers are looking into its use in skincare products for its potential to improve skin health and appearance, leveraging its antioxidant properties.

Biochemical Studies: It serves as a model compound in biochemical research to understand amino acid interactions and their effects on biological systems, aiding in various scientific inquiries.

References Data Source From Pubchem

Copper-carbidopa nanoparticles as highly active laccase-mimics for colorimetric detection and oxidative catalysis of o-phenylenediamine

Publication Name: Journal of Analytical Science and Technology
Publication Date: 2026-02-13
DOI: 10.1186/s40543-026-00528-1

Efficacy of pharmacological agents for management of post-partum hypertension: A systematic review and network meta-analysis

Publication Name: Journal of Human Hypertension
Publication Date: 2026-02-09
DOI: 10.1038/s41371-026-01120-1

[ESC Guidelines on cardiovascular diseases and pregnancy-most important facts of the 2025 update]

Publication Name: Herz
Publication Date: 2026-02
DOI: 10.1007/s00059-025-05358-2

Interpretation of the Urinalysis and Urine Microscopy

Publication Name: Current Treatment Options in Pediatrics
Publication Date: 2026-01-30
DOI: 10.1007/s40746-026-00363-x